A high-throughput screen for quorum-sensing inhibitors that target acyl-homoserine lactone synthases
Many Proteobacteria use N -acyl-homoserine lactone (acyl-HSL) quorum sensing to control specific genes. Acyl-HSL synthesis requires unique enzymes that use S -adenosyl methionine as an acyl acceptor and amino acid donor. We developed and executed an enzyme-coupled high-throughput cell-free screen to discover acyl-HSL synthase inhibitors. The three strongest inhibitors were equally active against two different acyl-HSL synthases: Burkholderia mallei BmaI1 and Yersinia pestis YspI. Two of these inhibitors showed activity in whole cells. The most potent compound behaves as a noncompetitive inhibitor with a K i of 0.7 µM and showed activity in a cell-based assay. Quorum-sensing signal synthesis inhibitors will be useful in attempts to understand acyl-HSL synthase catalysis and as a tool in studies of quorum-sensing control of gene expression. Because acyl-HSL quorum-sensing controls virulence of some bacterial pathogens, anti–quorum-sensing chemicals have been sought as potential therapeutic agents. Our screen and identification of acyl-HSL synthase inhibitors serve as a basis for efforts to target quorum-sensing signal synthesis as an antivirulence approach.
Top-30
Journals
|
1
2
3
|
|
|
Frontiers in Microbiology
3 publications, 3.85%
|
|
|
ACS Chemical Biology
3 publications, 3.85%
|
|
|
Chemical Communications
3 publications, 3.85%
|
|
|
FEMS Microbiology Reviews
3 publications, 3.85%
|
|
|
Microbiology
2 publications, 2.56%
|
|
|
Life
2 publications, 2.56%
|
|
|
Frontiers in Cellular and Infection Microbiology
2 publications, 2.56%
|
|
|
Scientific Reports
2 publications, 2.56%
|
|
|
European Journal of Medicinal Chemistry
2 publications, 2.56%
|
|
|
ChemBioChem
2 publications, 2.56%
|
|
|
Biochemistry
2 publications, 2.56%
|
|
|
Microbiology spectrum
2 publications, 2.56%
|
|
|
Bioorganic and Medicinal Chemistry
1 publication, 1.28%
|
|
|
Frontiers in Pharmacology
1 publication, 1.28%
|
|
|
Pharmaceuticals
1 publication, 1.28%
|
|
|
BMC Microbiology
1 publication, 1.28%
|
|
|
Science China Life Sciences
1 publication, 1.28%
|
|
|
Current Tropical Medicine Reports
1 publication, 1.28%
|
|
|
Nature
1 publication, 1.28%
|
|
|
Cellular and Molecular Life Sciences
1 publication, 1.28%
|
|
|
Journal of Antibiotics
1 publication, 1.28%
|
|
|
PLoS ONE
1 publication, 1.28%
|
|
|
Journal of Colloid and Interface Science
1 publication, 1.28%
|
|
|
Computational and Structural Biotechnology Journal
1 publication, 1.28%
|
|
|
Bioorganic and Medicinal Chemistry Letters
1 publication, 1.28%
|
|
|
Tetrahedron
1 publication, 1.28%
|
|
|
Bioorganic Chemistry
1 publication, 1.28%
|
|
|
Trends in Microbiology
1 publication, 1.28%
|
|
|
MicrobiologyOpen
1 publication, 1.28%
|
|
|
1
2
3
|
Publishers
|
2
4
6
8
10
12
|
|
|
Elsevier
12 publications, 15.38%
|
|
|
Springer Nature
12 publications, 15.38%
|
|
|
American Chemical Society (ACS)
8 publications, 10.26%
|
|
|
Frontiers Media S.A.
6 publications, 7.69%
|
|
|
Wiley
5 publications, 6.41%
|
|
|
MDPI
4 publications, 5.13%
|
|
|
Royal Society of Chemistry (RSC)
4 publications, 5.13%
|
|
|
Taylor & Francis
4 publications, 5.13%
|
|
|
American Society for Microbiology
4 publications, 5.13%
|
|
|
Oxford University Press
3 publications, 3.85%
|
|
|
Cold Spring Harbor Laboratory
3 publications, 3.85%
|
|
|
Microbiology Society
2 publications, 2.56%
|
|
|
Public Library of Science (PLoS)
1 publication, 1.28%
|
|
|
Institute of Electrical and Electronics Engineers (IEEE)
1 publication, 1.28%
|
|
|
Proceedings of the National Academy of Sciences (PNAS)
1 publication, 1.28%
|
|
|
IntechOpen
1 publication, 1.28%
|
|
|
Ovid Technologies (Wolters Kluwer Health)
1 publication, 1.28%
|
|
|
Pesticide Science Society of Japan
1 publication, 1.28%
|
|
|
Autonomous Non-profit Organization Editorial Board of the journal Uspekhi Khimii
1 publication, 1.28%
|
|
|
2
4
6
8
10
12
|
- We do not take into account publications without a DOI.
- Statistics recalculated weekly.